The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved
• The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapid...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Coperchini, Francesca [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2021transfer abstract |
|---|
| Schlagwörter: |
|---|
| Umfang: |
10 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study - Lee, Myung Kyung ELSEVIER, 2021, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:58 ; year:2021 ; pages:82-91 ; extent:10 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.cytogfr.2020.12.005 |
|---|
| Katalog-ID: |
ELV053548094 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV053548094 | ||
| 003 | DE-627 | ||
| 005 | 20230626035014.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cytogfr.2020.12.005 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001343.pica |
| 035 | |a (DE-627)ELV053548094 | ||
| 035 | |a (ELSEVIER)S1359-6101(20)30242-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.81 |2 bkl | ||
| 084 | |a 44.63 |2 bkl | ||
| 100 | 1 | |a Coperchini, Francesca |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved |
| 264 | 1 | |c 2021transfer abstract | |
| 300 | |a 10 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. | ||
| 520 | |a • The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. | ||
| 650 | 7 | |a TNFα |2 Elsevier | |
| 650 | 7 | |a CXCL9 |2 Elsevier | |
| 650 | 7 | |a CXCL8 |2 Elsevier | |
| 650 | 7 | |a SARS-COV-2 |2 Elsevier | |
| 650 | 7 | |a MERS-CoV |2 Elsevier | |
| 650 | 7 | |a CXCL1 |2 Elsevier | |
| 650 | 7 | |a IFN-γ |2 Elsevier | |
| 650 | 7 | |a scRNA-seq |2 Elsevier | |
| 650 | 7 | |a CXCR3 |2 Elsevier | |
| 650 | 7 | |a CCL5 |2 Elsevier | |
| 650 | 7 | |a CCL3 |2 Elsevier | |
| 650 | 7 | |a CCL2 |2 Elsevier | |
| 650 | 7 | |a ssGSEA |2 Elsevier | |
| 650 | 7 | |a CCL19 |2 Elsevier | |
| 650 | 7 | |a Th17 |2 Elsevier | |
| 650 | 7 | |a HIV-1-2 |2 Elsevier | |
| 650 | 7 | |a ARDS |2 Elsevier | |
| 650 | 7 | |a Covid-19 |2 Elsevier | |
| 650 | 7 | |a IL-1 |2 Elsevier | |
| 650 | 7 | |a CCL20 |2 Elsevier | |
| 650 | 7 | |a IL1β |2 Elsevier | |
| 650 | 7 | |a BALF |2 Elsevier | |
| 650 | 7 | |a PBMC |2 Elsevier | |
| 650 | 7 | |a IL-6 |2 Elsevier | |
| 650 | 7 | |a GSCF |2 Elsevier | |
| 650 | 7 | |a CS |2 Elsevier | |
| 650 | 7 | |a CXCL10 |2 Elsevier | |
| 650 | 7 | |a MIS-C |2 Elsevier | |
| 650 | 7 | |a RNA-Seq |2 Elsevier | |
| 650 | 7 | |a JAK |2 Elsevier | |
| 650 | 7 | |a IL-17 |2 Elsevier | |
| 650 | 7 | |a ICU |2 Elsevier | |
| 650 | 7 | |a ACE-2 |2 Elsevier | |
| 650 | 7 | |a ATP |2 Elsevier | |
| 700 | 1 | |a Chiovato, Luca |4 oth | |
| 700 | 1 | |a Ricci, Gianluca |4 oth | |
| 700 | 1 | |a Croce, Laura |4 oth | |
| 700 | 1 | |a Magri, Flavia |4 oth | |
| 700 | 1 | |a Rotondi, Mario |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Lee, Myung Kyung ELSEVIER |t Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study |d 2021 |g Amsterdam [u.a.] |w (DE-627)ELV007431309 |
| 773 | 1 | 8 | |g volume:58 |g year:2021 |g pages:82-91 |g extent:10 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.cytogfr.2020.12.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.81 |j Onkologie |q VZ |
| 936 | b | k | |a 44.63 |j Krankenpflege |q VZ |
| 951 | |a AR | ||
| 952 | |d 58 |j 2021 |h 82-91 |g 10 | ||
| author_variant |
f c fc |
|---|---|
| matchkey_str |
coperchinifrancescachiovatolucariccigian:2021----:hctknsomnoi1frhrdacsnuudrtnighrlos |
| hierarchy_sort_str |
2021transfer abstract |
| bklnumber |
44.81 44.63 |
| publishDate |
2021 |
| allfields |
10.1016/j.cytogfr.2020.12.005 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001343.pica (DE-627)ELV053548094 (ELSEVIER)S1359-6101(20)30242-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.81 bkl 44.63 bkl Coperchini, Francesca verfasserin aut The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved 2021transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. • The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. TNFα Elsevier CXCL9 Elsevier CXCL8 Elsevier SARS-COV-2 Elsevier MERS-CoV Elsevier CXCL1 Elsevier IFN-γ Elsevier scRNA-seq Elsevier CXCR3 Elsevier CCL5 Elsevier CCL3 Elsevier CCL2 Elsevier ssGSEA Elsevier CCL19 Elsevier Th17 Elsevier HIV-1-2 Elsevier ARDS Elsevier Covid-19 Elsevier IL-1 Elsevier CCL20 Elsevier IL1β Elsevier BALF Elsevier PBMC Elsevier IL-6 Elsevier GSCF Elsevier CS Elsevier CXCL10 Elsevier MIS-C Elsevier RNA-Seq Elsevier JAK Elsevier IL-17 Elsevier ICU Elsevier ACE-2 Elsevier ATP Elsevier Chiovato, Luca oth Ricci, Gianluca oth Croce, Laura oth Magri, Flavia oth Rotondi, Mario oth Enthalten in Elsevier Science Lee, Myung Kyung ELSEVIER Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study 2021 Amsterdam [u.a.] (DE-627)ELV007431309 volume:58 year:2021 pages:82-91 extent:10 https://doi.org/10.1016/j.cytogfr.2020.12.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.81 Onkologie VZ 44.63 Krankenpflege VZ AR 58 2021 82-91 10 |
| spelling |
10.1016/j.cytogfr.2020.12.005 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001343.pica (DE-627)ELV053548094 (ELSEVIER)S1359-6101(20)30242-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.81 bkl 44.63 bkl Coperchini, Francesca verfasserin aut The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved 2021transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. • The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. TNFα Elsevier CXCL9 Elsevier CXCL8 Elsevier SARS-COV-2 Elsevier MERS-CoV Elsevier CXCL1 Elsevier IFN-γ Elsevier scRNA-seq Elsevier CXCR3 Elsevier CCL5 Elsevier CCL3 Elsevier CCL2 Elsevier ssGSEA Elsevier CCL19 Elsevier Th17 Elsevier HIV-1-2 Elsevier ARDS Elsevier Covid-19 Elsevier IL-1 Elsevier CCL20 Elsevier IL1β Elsevier BALF Elsevier PBMC Elsevier IL-6 Elsevier GSCF Elsevier CS Elsevier CXCL10 Elsevier MIS-C Elsevier RNA-Seq Elsevier JAK Elsevier IL-17 Elsevier ICU Elsevier ACE-2 Elsevier ATP Elsevier Chiovato, Luca oth Ricci, Gianluca oth Croce, Laura oth Magri, Flavia oth Rotondi, Mario oth Enthalten in Elsevier Science Lee, Myung Kyung ELSEVIER Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study 2021 Amsterdam [u.a.] (DE-627)ELV007431309 volume:58 year:2021 pages:82-91 extent:10 https://doi.org/10.1016/j.cytogfr.2020.12.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.81 Onkologie VZ 44.63 Krankenpflege VZ AR 58 2021 82-91 10 |
| allfields_unstemmed |
10.1016/j.cytogfr.2020.12.005 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001343.pica (DE-627)ELV053548094 (ELSEVIER)S1359-6101(20)30242-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.81 bkl 44.63 bkl Coperchini, Francesca verfasserin aut The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved 2021transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. • The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. TNFα Elsevier CXCL9 Elsevier CXCL8 Elsevier SARS-COV-2 Elsevier MERS-CoV Elsevier CXCL1 Elsevier IFN-γ Elsevier scRNA-seq Elsevier CXCR3 Elsevier CCL5 Elsevier CCL3 Elsevier CCL2 Elsevier ssGSEA Elsevier CCL19 Elsevier Th17 Elsevier HIV-1-2 Elsevier ARDS Elsevier Covid-19 Elsevier IL-1 Elsevier CCL20 Elsevier IL1β Elsevier BALF Elsevier PBMC Elsevier IL-6 Elsevier GSCF Elsevier CS Elsevier CXCL10 Elsevier MIS-C Elsevier RNA-Seq Elsevier JAK Elsevier IL-17 Elsevier ICU Elsevier ACE-2 Elsevier ATP Elsevier Chiovato, Luca oth Ricci, Gianluca oth Croce, Laura oth Magri, Flavia oth Rotondi, Mario oth Enthalten in Elsevier Science Lee, Myung Kyung ELSEVIER Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study 2021 Amsterdam [u.a.] (DE-627)ELV007431309 volume:58 year:2021 pages:82-91 extent:10 https://doi.org/10.1016/j.cytogfr.2020.12.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.81 Onkologie VZ 44.63 Krankenpflege VZ AR 58 2021 82-91 10 |
| allfieldsGer |
10.1016/j.cytogfr.2020.12.005 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001343.pica (DE-627)ELV053548094 (ELSEVIER)S1359-6101(20)30242-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.81 bkl 44.63 bkl Coperchini, Francesca verfasserin aut The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved 2021transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. • The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. TNFα Elsevier CXCL9 Elsevier CXCL8 Elsevier SARS-COV-2 Elsevier MERS-CoV Elsevier CXCL1 Elsevier IFN-γ Elsevier scRNA-seq Elsevier CXCR3 Elsevier CCL5 Elsevier CCL3 Elsevier CCL2 Elsevier ssGSEA Elsevier CCL19 Elsevier Th17 Elsevier HIV-1-2 Elsevier ARDS Elsevier Covid-19 Elsevier IL-1 Elsevier CCL20 Elsevier IL1β Elsevier BALF Elsevier PBMC Elsevier IL-6 Elsevier GSCF Elsevier CS Elsevier CXCL10 Elsevier MIS-C Elsevier RNA-Seq Elsevier JAK Elsevier IL-17 Elsevier ICU Elsevier ACE-2 Elsevier ATP Elsevier Chiovato, Luca oth Ricci, Gianluca oth Croce, Laura oth Magri, Flavia oth Rotondi, Mario oth Enthalten in Elsevier Science Lee, Myung Kyung ELSEVIER Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study 2021 Amsterdam [u.a.] (DE-627)ELV007431309 volume:58 year:2021 pages:82-91 extent:10 https://doi.org/10.1016/j.cytogfr.2020.12.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.81 Onkologie VZ 44.63 Krankenpflege VZ AR 58 2021 82-91 10 |
| allfieldsSound |
10.1016/j.cytogfr.2020.12.005 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001343.pica (DE-627)ELV053548094 (ELSEVIER)S1359-6101(20)30242-2 DE-627 ger DE-627 rakwb eng 610 VZ 44.81 bkl 44.63 bkl Coperchini, Francesca verfasserin aut The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved 2021transfer abstract 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. • The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. TNFα Elsevier CXCL9 Elsevier CXCL8 Elsevier SARS-COV-2 Elsevier MERS-CoV Elsevier CXCL1 Elsevier IFN-γ Elsevier scRNA-seq Elsevier CXCR3 Elsevier CCL5 Elsevier CCL3 Elsevier CCL2 Elsevier ssGSEA Elsevier CCL19 Elsevier Th17 Elsevier HIV-1-2 Elsevier ARDS Elsevier Covid-19 Elsevier IL-1 Elsevier CCL20 Elsevier IL1β Elsevier BALF Elsevier PBMC Elsevier IL-6 Elsevier GSCF Elsevier CS Elsevier CXCL10 Elsevier MIS-C Elsevier RNA-Seq Elsevier JAK Elsevier IL-17 Elsevier ICU Elsevier ACE-2 Elsevier ATP Elsevier Chiovato, Luca oth Ricci, Gianluca oth Croce, Laura oth Magri, Flavia oth Rotondi, Mario oth Enthalten in Elsevier Science Lee, Myung Kyung ELSEVIER Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study 2021 Amsterdam [u.a.] (DE-627)ELV007431309 volume:58 year:2021 pages:82-91 extent:10 https://doi.org/10.1016/j.cytogfr.2020.12.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.81 Onkologie VZ 44.63 Krankenpflege VZ AR 58 2021 82-91 10 |
| language |
English |
| source |
Enthalten in Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study Amsterdam [u.a.] volume:58 year:2021 pages:82-91 extent:10 |
| sourceStr |
Enthalten in Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study Amsterdam [u.a.] volume:58 year:2021 pages:82-91 extent:10 |
| format_phy_str_mv |
Article |
| bklname |
Onkologie Krankenpflege |
| institution |
findex.gbv.de |
| topic_facet |
TNFα CXCL9 CXCL8 SARS-COV-2 MERS-CoV CXCL1 IFN-γ scRNA-seq CXCR3 CCL5 CCL3 CCL2 ssGSEA CCL19 Th17 HIV-1-2 ARDS Covid-19 IL-1 CCL20 IL1β BALF PBMC IL-6 GSCF CS CXCL10 MIS-C RNA-Seq JAK IL-17 ICU ACE-2 ATP |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study |
| authorswithroles_txt_mv |
Coperchini, Francesca @@aut@@ Chiovato, Luca @@oth@@ Ricci, Gianluca @@oth@@ Croce, Laura @@oth@@ Magri, Flavia @@oth@@ Rotondi, Mario @@oth@@ |
| publishDateDaySort_date |
2021-01-01T00:00:00Z |
| hierarchy_top_id |
ELV007431309 |
| dewey-sort |
3610 |
| id |
ELV053548094 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV053548094</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626035014.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.cytogfr.2020.12.005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001343.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV053548094</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1359-6101(20)30242-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.81</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.63</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Coperchini, Francesca</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TNFα</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CXCL9</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CXCL8</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SARS-COV-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MERS-CoV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CXCL1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IFN-γ</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">scRNA-seq</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CXCR3</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CCL5</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CCL3</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CCL2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ssGSEA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CCL19</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Th17</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HIV-1-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ARDS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Covid-19</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IL-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CCL20</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IL1β</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BALF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PBMC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IL-6</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GSCF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CXCL10</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MIS-C</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RNA-Seq</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">JAK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IL-17</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ICU</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ACE-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ATP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chiovato, Luca</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ricci, Gianluca</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Croce, Laura</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Magri, Flavia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rotondi, Mario</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Lee, Myung Kyung ELSEVIER</subfield><subfield code="t">Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007431309</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:58</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:82-91</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.cytogfr.2020.12.005</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.81</subfield><subfield code="j">Onkologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.63</subfield><subfield code="j">Krankenpflege</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">58</subfield><subfield code="j">2021</subfield><subfield code="h">82-91</subfield><subfield code="g">10</subfield></datafield></record></collection>
|
| author |
Coperchini, Francesca |
| spellingShingle |
Coperchini, Francesca ddc 610 bkl 44.81 bkl 44.63 Elsevier TNFα Elsevier CXCL9 Elsevier CXCL8 Elsevier SARS-COV-2 Elsevier MERS-CoV Elsevier CXCL1 Elsevier IFN-γ Elsevier scRNA-seq Elsevier CXCR3 Elsevier CCL5 Elsevier CCL3 Elsevier CCL2 Elsevier ssGSEA Elsevier CCL19 Elsevier Th17 Elsevier HIV-1-2 Elsevier ARDS Elsevier Covid-19 Elsevier IL-1 Elsevier CCL20 Elsevier IL1β Elsevier BALF Elsevier PBMC Elsevier IL-6 Elsevier GSCF Elsevier CS Elsevier CXCL10 Elsevier MIS-C Elsevier RNA-Seq Elsevier JAK Elsevier IL-17 Elsevier ICU Elsevier ACE-2 Elsevier ATP The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved |
| authorStr |
Coperchini, Francesca |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV007431309 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 VZ 44.81 bkl 44.63 bkl The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved TNFα Elsevier CXCL9 Elsevier CXCL8 Elsevier SARS-COV-2 Elsevier MERS-CoV Elsevier CXCL1 Elsevier IFN-γ Elsevier scRNA-seq Elsevier CXCR3 Elsevier CCL5 Elsevier CCL3 Elsevier CCL2 Elsevier ssGSEA Elsevier CCL19 Elsevier Th17 Elsevier HIV-1-2 Elsevier ARDS Elsevier Covid-19 Elsevier IL-1 Elsevier CCL20 Elsevier IL1β Elsevier BALF Elsevier PBMC Elsevier IL-6 Elsevier GSCF Elsevier CS Elsevier CXCL10 Elsevier MIS-C Elsevier RNA-Seq Elsevier JAK Elsevier IL-17 Elsevier ICU Elsevier ACE-2 Elsevier ATP Elsevier |
| topic |
ddc 610 bkl 44.81 bkl 44.63 Elsevier TNFα Elsevier CXCL9 Elsevier CXCL8 Elsevier SARS-COV-2 Elsevier MERS-CoV Elsevier CXCL1 Elsevier IFN-γ Elsevier scRNA-seq Elsevier CXCR3 Elsevier CCL5 Elsevier CCL3 Elsevier CCL2 Elsevier ssGSEA Elsevier CCL19 Elsevier Th17 Elsevier HIV-1-2 Elsevier ARDS Elsevier Covid-19 Elsevier IL-1 Elsevier CCL20 Elsevier IL1β Elsevier BALF Elsevier PBMC Elsevier IL-6 Elsevier GSCF Elsevier CS Elsevier CXCL10 Elsevier MIS-C Elsevier RNA-Seq Elsevier JAK Elsevier IL-17 Elsevier ICU Elsevier ACE-2 Elsevier ATP |
| topic_unstemmed |
ddc 610 bkl 44.81 bkl 44.63 Elsevier TNFα Elsevier CXCL9 Elsevier CXCL8 Elsevier SARS-COV-2 Elsevier MERS-CoV Elsevier CXCL1 Elsevier IFN-γ Elsevier scRNA-seq Elsevier CXCR3 Elsevier CCL5 Elsevier CCL3 Elsevier CCL2 Elsevier ssGSEA Elsevier CCL19 Elsevier Th17 Elsevier HIV-1-2 Elsevier ARDS Elsevier Covid-19 Elsevier IL-1 Elsevier CCL20 Elsevier IL1β Elsevier BALF Elsevier PBMC Elsevier IL-6 Elsevier GSCF Elsevier CS Elsevier CXCL10 Elsevier MIS-C Elsevier RNA-Seq Elsevier JAK Elsevier IL-17 Elsevier ICU Elsevier ACE-2 Elsevier ATP |
| topic_browse |
ddc 610 bkl 44.81 bkl 44.63 Elsevier TNFα Elsevier CXCL9 Elsevier CXCL8 Elsevier SARS-COV-2 Elsevier MERS-CoV Elsevier CXCL1 Elsevier IFN-γ Elsevier scRNA-seq Elsevier CXCR3 Elsevier CCL5 Elsevier CCL3 Elsevier CCL2 Elsevier ssGSEA Elsevier CCL19 Elsevier Th17 Elsevier HIV-1-2 Elsevier ARDS Elsevier Covid-19 Elsevier IL-1 Elsevier CCL20 Elsevier IL1β Elsevier BALF Elsevier PBMC Elsevier IL-6 Elsevier GSCF Elsevier CS Elsevier CXCL10 Elsevier MIS-C Elsevier RNA-Seq Elsevier JAK Elsevier IL-17 Elsevier ICU Elsevier ACE-2 Elsevier ATP |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
l c lc g r gr l c lc f m fm m r mr |
| hierarchy_parent_title |
Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study |
| hierarchy_parent_id |
ELV007431309 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV007431309 |
| title |
The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved |
| ctrlnum |
(DE-627)ELV053548094 (ELSEVIER)S1359-6101(20)30242-2 |
| title_full |
The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved |
| author_sort |
Coperchini, Francesca |
| journal |
Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study |
| journalStr |
Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2021 |
| contenttype_str_mv |
zzz |
| container_start_page |
82 |
| author_browse |
Coperchini, Francesca |
| container_volume |
58 |
| physical |
10 |
| class |
610 VZ 44.81 bkl 44.63 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Coperchini, Francesca |
| doi_str_mv |
10.1016/j.cytogfr.2020.12.005 |
| dewey-full |
610 |
| title_sort |
cytokine storm in covid-19: further advances in our understanding the role of specific chemokines involved |
| title_auth |
The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved |
| abstract |
• The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. |
| abstractGer |
• The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. |
| abstract_unstemmed |
• The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved |
| url |
https://doi.org/10.1016/j.cytogfr.2020.12.005 |
| remote_bool |
true |
| author2 |
Chiovato, Luca Ricci, Gianluca Croce, Laura Magri, Flavia Rotondi, Mario |
| author2Str |
Chiovato, Luca Ricci, Gianluca Croce, Laura Magri, Flavia Rotondi, Mario |
| ppnlink |
ELV007431309 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/j.cytogfr.2020.12.005 |
| up_date |
2024-07-06T19:14:50.163Z |
| _version_ |
1803858257027006464 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV053548094</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626035014.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2021 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.cytogfr.2020.12.005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001343.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV053548094</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1359-6101(20)30242-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.81</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.63</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Coperchini, Francesca</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2021transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• The “cytokine storm” is one of the most dangerous and potentially life-threatening event related to COVID-19 sustaining its major clinical complications. • Early studies already indicated that the chemokine/chemokine receptor system largely contributed to the onset of the “cytokine storm”. • Rapidly growing evidences supported a major role of specific chemokines in driving a more or less severe clinical course of Sars-Cov-2 infection. • At the present, CXCL10 and CCL2 represent, at the present, the chemokines identified to play a major role in driving a more severe course of COVID-19, potentially serving as a marker for predicting the clinical outcome. • Owing to the great effort of the Scientific Community, in increasing our knowledge on COVID-19, it is likely that also other chemokines will be further investigated in the next future.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">TNFα</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CXCL9</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CXCL8</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SARS-COV-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MERS-CoV</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CXCL1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IFN-γ</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">scRNA-seq</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CXCR3</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CCL5</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CCL3</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CCL2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ssGSEA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CCL19</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Th17</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HIV-1-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ARDS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Covid-19</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IL-1</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CCL20</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IL1β</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">BALF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PBMC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IL-6</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">GSCF</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CS</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CXCL10</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MIS-C</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">RNA-Seq</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">JAK</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IL-17</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ICU</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ACE-2</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">ATP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chiovato, Luca</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ricci, Gianluca</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Croce, Laura</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Magri, Flavia</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rotondi, Mario</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Lee, Myung Kyung ELSEVIER</subfield><subfield code="t">Decisional balance, self-leadership, self-efficacy, planning, and stages of change in adopting exercise behaviors in patients with stomach cancer: A cross-sectional study</subfield><subfield code="d">2021</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV007431309</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:58</subfield><subfield code="g">year:2021</subfield><subfield code="g">pages:82-91</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.cytogfr.2020.12.005</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.81</subfield><subfield code="j">Onkologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.63</subfield><subfield code="j">Krankenpflege</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">58</subfield><subfield code="j">2021</subfield><subfield code="h">82-91</subfield><subfield code="g">10</subfield></datafield></record></collection>
|
| score |
7.402261 |